InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,414.80
(
0.00%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.37
(
-0.26%
)
Bitcoin
63,827.25
(
-0.69%
)
Post# of 1189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MikeCr

Send PM Follow Ignore
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

MikeCr

Re: None

Sunday, 07/17/2016 1:26:42 PM

Sunday, July 17, 2016 1:26:42 PM

Post# of 1189

Everett Jolly Interviews Greg Linn, CEO for Avant Diagnostics Inc. (AVDX), and they discuss their exponential growth for 2016 and their recent acquisition.



July 15, 2016 Radio interview

https://upticknewswire.com/greg-lynn-ceo-of-avant-diagnostics-inc-discusses-their-exponential-growth-for-2016/

Cant's say that I learned anything new. Linn evaded the question about where AVDX stands with the clinical trials of the assays they have.

Linn said the float is 2.5M shares out of the 210M outstanding shares.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up